Fox Chase Cancer Center News

PHILADELPHIA (June 13, 2019) — Jessica Bauman, MD, an assistant professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, recently received a grant in conjunction with the University of Colorado Denver from the National Institute of Nursing Research.

PHILADELPHIA (June 7, 2019) – Fox Chase Cancer Center has earned CEO Cancer Gold Standard re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the latest comprehensive requirements of the Gold Standard.

PHILADELPHIA (May 23, 2019) — A new combination of established kidney cancer drugs has demonstrated safety and encouraging efficacy in patients with metastatic renal cell carcinoma (mRCC),  according to a new clinical trial lead by Matthew Zibelman, MD, on the combination of Axitinib and the PD-1 inhibitor Nivolumab.

PHILADELPHIA (May 22, 2019) – Michael Hall, MD, MS, has been named chair of the Department of Clinical Genetics at Fox Chase Cancer Center. Dr. Hall will continue to serve in his other roles at Fox Chase

PHILADELPHIA (May 22, 2019) – Scientific trainees and senior faculty members will host the annual Immersion Science Program (ISP) Career Development Symposium at The Franklin Institute (222 North 20th St, Philadelphia, PA 19103) on May 29th, 2019 from 10:00 am - 1:00 pm.

PHILADELPHIA (May 21, 2019) – The award recognizes Fox Chase Cancer Center’s outstanding effort to enhance its processes for managing patient discharge planning and care transitions.

PHILADELPHIA (May 15, 2019) — Camille Ragin, PhD, has received a grant from the National Cancer Institute for her research on a possible genetic explanation for racial disparities in oral cavity and laryngeal cancer survival rates.

PHILADELPHIA (May 14, 2019) — Fox Chase Cancer Center has appointed five new endowed chairs.

Private philanthropy is critical to the advancement of cancer research. With sincere gratitude to our donors for their generosity, we at Fox Chase Cancer Center steward our institution’s endowment for the betterment of all who face cancer. It is our pleasure to announce our newly appointed endowed chair holders, to whom we entrust the great responsibility of leading research that will take us further in our understanding of cancer.